Most often associated with treatment of Acute Myelogenous Leukemia (AML).
Treatment of chronic lymphocytic leukemia (CLL), including CLL that has not responded to or reoccurred after standard therapy.
Salvage therapy for non-Hodgkin's lymphoma and acute leukemias.
(Cytosar-U®, Ara-C, Arabinosylcytosine)
Cytarabine is used to treat different forms of leukemia, including acute and chronic myelogenous (AML and CML) and acute lymphocytic leukemia (ALL). It is also used to treat lymphoma, meningeal leukemia and lymphoma (cancers found in the lining of the brain and spinal cord)
(Idamycin®, Idamycin PFS®)
Idarubicin is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes.
Used to treat Myelodysplastic syndromes, Chronic myelogenous leukemia (in blast crisis), Acute lymphoblastic leukemia, and Acute myelogenous leukemia.